• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国重大传染病报销政策取得成功。

Success of Big Infectious Disease Reimbursement Policy in China.

作者信息

Nie Kun-Xi, Wang Chan, Li Xin-Wu

机构信息

Shihezi University, Guangzhou, P.R. China.

Guangdong University of Finance & Economics, Guangzhou, P.R. China.

出版信息

Inquiry. 2020 Jan-Dec;57:46958020907788. doi: 10.1177/0046958020907788.

DOI:10.1177/0046958020907788
PMID:32075479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7036499/
Abstract

Big infectious diseases do harm to the whole society, and it is highly crucial to control them on time. The major purpose of this article is to theoretically demonstrate that the Chinese government's intervention in large-scale infectious diseases is successful and efficient. Two potential strategies were considered: strategy 1 was infectious disease without government intervention, and strategy 2 was infectious disease with government intervention. By evolution model, this article illustrates the efficiency of big infectious disease reimbursement policy in China. Without government reimbursement, this article finds that high expenditures accelerate the disease infection. The number of infected persons decreases under big infectious disease reimbursement policy in China. The higher the treatment costs, the more important the government intervention. Big infectious disease reimbursement policy in China can serve as an efficient example to cope with big infectious diseases.

摘要

重大传染病对整个社会造成危害,及时控制至关重要。本文的主要目的是从理论上证明中国政府对大规模传染病的干预是成功且有效的。考虑了两种潜在策略:策略1是无政府干预的传染病情况,策略2是有政府干预的传染病情况。通过演化模型,本文阐述了中国重大传染病报销政策的有效性。在没有政府报销的情况下,本文发现高支出会加速疾病传播。在中国重大传染病报销政策下,感染人数会减少。治疗成本越高,政府干预就越重要。中国的重大传染病报销政策可以作为应对重大传染病的一个有效范例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/7036499/17f2de1b2719/10.1177_0046958020907788-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/7036499/3caed9ac9896/10.1177_0046958020907788-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/7036499/c38c5552a656/10.1177_0046958020907788-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/7036499/3d9356d5b927/10.1177_0046958020907788-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/7036499/17f2de1b2719/10.1177_0046958020907788-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/7036499/3caed9ac9896/10.1177_0046958020907788-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/7036499/c38c5552a656/10.1177_0046958020907788-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/7036499/3d9356d5b927/10.1177_0046958020907788-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad98/7036499/17f2de1b2719/10.1177_0046958020907788-fig4.jpg

相似文献

1
Success of Big Infectious Disease Reimbursement Policy in China.中国重大传染病报销政策取得成功。
Inquiry. 2020 Jan-Dec;57:46958020907788. doi: 10.1177/0046958020907788.
2
The impact of increased reimbursement rates under the new cooperative medical scheme on the financial burden of tuberculosis patients.新合作医疗方案下提高报销比例对结核病人经济负担的影响。
Infect Dis Poverty. 2019 Aug 2;8(1):67. doi: 10.1186/s40249-019-0575-z.
3
The consequences of paying Medicare managed care plans their costs.向医疗保险管理式医疗计划支付其费用的后果。
Inquiry. 1998 Summer;35(2):210-22.
4
Correlation Between New Cooperative Medical Scheme Policy Design and Catastrophic Medical Payment: Evidence From 25 Counties in Rural China.新型农村合作医疗政策设计与灾难性医疗支出的相关性:来自中国农村25个县的证据
Asia Pac J Public Health. 2016 Jan;28(1):26-38. doi: 10.1177/1010539515612907. Epub 2015 Oct 28.
5
Comparing Maternal Services Utilization and Expense Reimbursement before and after the Adjustment of the New Rural Cooperative Medical Scheme Policy in Rural China.中国农村新型农村合作医疗制度政策调整前后孕产妇服务利用及费用报销情况比较
PLoS One. 2016 Jul 7;11(7):e0158473. doi: 10.1371/journal.pone.0158473. eCollection 2016.
6
Issues in drug pricing, reimbursement, and access in China with references to other Asia-Pacific region.中国药品定价、报销及可及性问题,并参考其他亚太地区情况。
Value Health. 2008 Mar;11 Suppl 1:S124-9. doi: 10.1111/j.1524-4733.2008.00376.x.
7
Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts.中国的药品定价与报销:整体为何小于部分之和。
Health Policy. 2016 May;120(5):519-34. doi: 10.1016/j.healthpol.2016.03.014. Epub 2016 Apr 12.
8
Improving the performance of social health insurance system through increasing outpatient expenditure reimbursement ratio: a quasi-experimental evaluation study from rural China.通过提高门诊支出报销比例来提高社会医疗保险制度绩效:来自中国农村的准实验评估研究。
Int J Equity Health. 2018 Jun 25;17(1):89. doi: 10.1186/s12939-018-0799-8.
9
New cooperative medical scheme decreased financial burden but expanded the gap of income-related inequity: evidence from three provinces in rural China.新型农村合作医疗减轻了经济负担,但扩大了收入相关不公平差距:来自中国农村三个省份的证据。
Int J Equity Health. 2016 May 4;15:72. doi: 10.1186/s12939-016-0361-5.
10
The Effect of the Full Coverage of Essential Medicines Policy on Utilization and Accessibility of Primary Healthcare Service for Rural Seniors: A Time Series Study in Qidong, China.基本药物全覆盖政策对农村老年人基层医疗服务利用和可及性的影响:来自中国启东的一个时间序列研究。
Int J Environ Res Public Health. 2019 Nov 6;16(22):4316. doi: 10.3390/ijerph16224316.

引用本文的文献

1
Microfluidics for COVID-19: From Current Work to Future Perspective.微流控技术在 COVID-19 中的应用:从当前工作到未来展望。
Biosensors (Basel). 2023 Jan 20;13(2):163. doi: 10.3390/bios13020163.
2
Explaining the challenges of the Iranian Health System in fighting the COVID-19 pandemic: A Qualitative Study.伊朗卫生系统在抗击 COVID-19 大流行中面临的挑战解释:一项定性研究。
J Prev Med Hyg. 2022 Jan 31;62(4):E841-E853. doi: 10.15167/2421-4248/jpmh2021.62.4.2230. eCollection 2021 Dec.
3
Point-of-care diagnostics for infectious diseases: From methods to devices.

本文引用的文献

1
Big Data Analytics, Infectious Diseases and Associated Ethical Impacts.大数据分析、传染病及相关伦理影响
Philos Technol. 2019;32(1):69-85. doi: 10.1007/s13347-017-0278-y. Epub 2017 Aug 24.
2
The impact of packaging and messaging on adherence to malaria treatment: Evidence from a randomized controlled trial in Uganda.包装和信息传递对疟疾治疗依从性的影响:来自乌干达一项随机对照试验的证据。
J Dev Econ. 2018 Sep;134:68-95. doi: 10.1016/j.jdeveco.2018.04.008.
3
Predicting Infectious Disease Using Deep Learning and Big Data.利用深度学习和大数据预测传染病。
传染病的即时诊断:从方法到设备。
Nano Today. 2021 Apr;37:101092. doi: 10.1016/j.nantod.2021.101092. Epub 2021 Feb 6.
Int J Environ Res Public Health. 2018 Jul 27;15(8):1596. doi: 10.3390/ijerph15081596.
4
Opportunities and challenges in modeling emerging infectious diseases.新兴传染病建模中的机遇与挑战。
Science. 2017 Jul 14;357(6347):149-152. doi: 10.1126/science.aam8335.
5
Emerging infectious diseases: A proactive approach.新发传染病:主动应对。
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4055-4059. doi: 10.1073/pnas.1701410114. Epub 2017 Apr 10.
6
Effects of asymmetric medical insurance subsidy on hospitals competition under non-price regulation.非价格管制下不对称医疗保险补贴对医院竞争的影响
Int J Equity Health. 2016 Nov 15;15(1):184. doi: 10.1186/s12939-016-0468-8.
7
Contributions to the mathematical theory of epidemics--I. 1927.对流行病数学理论的贡献——I. 1927年。
Bull Math Biol. 1991;53(1-2):33-55. doi: 10.1007/BF02464423.